Pancreatic Cancer Research

ResearcherNantong UniversityActive in the last 2 years

Weifeng Ding

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1713-3275; OpenAlex author ID A5103229391. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 2 papers

Papers 3

  1. Combined ultrasound endoscopy-guided fine-needle aspiration with DNA methylation of SHOX2 and RASSF1A genes to enhance the auxiliary diagnostic precision of pa… Co-author DOI 10.1016/j.heliyon.2024.e34028↗
  2. Integrated ctDNA Methylation Profiling of P2RX1, CBFA2T3, and CERS4 as Pancreatic Ductal Adenocarcinoma Biomarkers: Identification and Mechanistic Insights Last author DOI 10.21203/rs.3.rs-4982255/v1↗
  3. Serum APRIL, a potential tumor marker in pancreatic cancer. Co-author DOI 10.1515/cclm.2011.608↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yangyang Shan · 1 shared paper, 2024 · strength 0.24
  2. Hongsheng Chen · 1 shared paper, 2024 · strength 0.24
  3. Jianfeng Zhang · 1 shared paper, 2024 · strength 0.24
  4. Xudong Wang · 1 shared paper, 2024 · strength 0.24
  5. Feng Wang · 1 shared paper, 2011 · strength 0.02
  6. Huimin Wang · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.